01865 261400

BOOK A TOUR

Absolute Antibody New Director Appointment

June 27th 2017

Absolute Antibody Ltd is pleased to announce the appointment of Stevan Hoyle as a Non-Executive
Director, effective immediately.

Stevan has spent most his career in telecommunications and was a Director in the Vodafone Group between 1999 and 2016. He is chair of an International recruitment company and board advisor to a Biotechnology consultancy.

Dr Nick Hutchings, CEO of Absolute Antibody Ltd, said: "We’re delighted to have Stevan join us at Absolute Antibody. His considerable experience of working in the Americas, Asia and Africa will be invaluable for our continued international growth.”

 

Stevan has spent most his career in telecommunications and was a Director in the Vodafone Group between 1999 and 2016. He is also chair of an International recruitment company and board advisor to a Biotechnology consultancy.

Absolute Antibody Ltd is a life sciences company developing next generation engineered antibodies for the biomedical research and diagnostics markets. View their full company profile here.

August 19th 2024

Five minutes with Kevin Maskell, CSO of Bioarchitech

The Wood Centre for Innovation welcomes Bioarchitech.

May 13th 2024

UK’s Quantum Leap in Navigation Technology – Infleqtion

Discover how Infleqion achieves a quantum leap in navigation technology, marking a significant milestone for British innovation and resilience against hostile actors.

September 27th 2023

Fusion technology company Oxford Sigma relocates HQ to Oxford Centre for Innovation

Oxford Sigma has returned to Oxford’s city centre to accelerate fusion materials technology commercialisation to help tackle climate change and resolve energy security, with new global headquarters at our Oxford Centre for Innovation.